The high cost of exogenous growth factors like BMP-2 remains a major financial barrier to the commercial production of living, engineered bone substitutes. For decades, the reliance on these expensive proteins has restricted high-end tissue engineering to academic research, but the landscape is
Engineering stable microbial cell factories requires genetic tools that function reliably when integrated into the chromosome rather than relying on high-copy plasmids. This foundational principle guided a recent high-impact collaboration between scientific teams in Argentina and Spain, who sought
Professor Alok Mishra of the Norwegian University of Science and Technology argues that a narrow focus on computational efficiency ignores the ecological damage caused by AI infrastructure. This perspective is vital as artificial intelligence transitions from an experimental novelty to the primary
Sustainability is increasingly viewed as a risk mitigation strategy rather than a simple cost center, directly enabling a site to double its capacity in the future. As the current landscape of late 2026 unfolds, the American biopharmaceutical manufacturing sector has transitioned from a period of
The traditional 'take-make-waste' model of medical manufacturing is being challenged by researchers who view the environmental footprint of healthcare as a critical engineering problem. For decades, the medical industry has operated under a strict mandate of patient safety and clinical sterility, a
By utilizing the natural reducing and capping agents found in Catharanthus roseus, researchers have developed a one-pot synthesis method that avoids the toxic solvents of industrial production. This breakthrough focuses on the Madagascar periwinkle, a plant traditionally valued for its life-saving
